>

Coloplast Financials

<div class='circular--portrait' style='background:#FF9E01;color: white;font-size:4em;padding-top: 25px;;'>CO</div>
Understanding current and past Coloplast Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. We suggest to use Coloplast B AS fundamental analysis to find out if markets are presently mispricing the company. Put another way you can use it to find out if Coloplast B AS is indeed mispriced or if you can make any profits on it by purchasing it and then waiting for the market to recognize its mistake and reprise the security. We found thirty-four available fundamental indicators for Coloplast B AS, which can be compared to its rivals. To make sure the equity is not overpriced, please confirm all Coloplast B AS financials, including its Price to Book, Revenue and the relationship between Price to Earning and Price to Sales .
View Fundamentals For
Refresh
With this module, you can determine Coloplast financials for your investing period. You should be able to track the changes in Coloplast individual fundamental values over time to develop the understanding of its risk, liquidity, profitability, or other critical and vital indicators.
1%1%

Chance of Financial Distress

Coloplast B AS has less than 1 (%) percent chance of experiencing financial distress in the next 2 years of operations. More Info

Coloplast Company Summary

Coloplast competes with ChemoMetec, and Zealand Pharma. Coloplast AS develops and markets intimate healthcare products and services worldwide. Coloplast AS was founded in 1954 and is headquartered in Humlebk, Denmark. Coloplast operates under Healthcare Products classification in Denmark and is traded on Copenhagen Stock Exchange. It employs 12000 people.
Specialization
Healthcare, Healthcare Products
InstrumentDenmark Stock View All
ExchangeCopenhagen Stock Exchange
ISINDK0060448595
Business AddressHoltedam 1-3
SectorHealthcare
IndustryMedical Instruments & Supplies
BenchmarkDOW
Websitewww.coloplast.com
Phone45 49 11 11 11
CurrencyDKK - Danish Krone

Coloplast Key Financial Ratios

Coloplast Financial Ratios Relationships

Coloplast B AS is number one stock in number of employees category among related companies. It is number one stock in current ratio category among related companies . The ratio of Number of Employees to Current Ratio for Coloplast B AS is about  10,714 

Coloplast Market Fundamentals

Follow Benchmarks with Macroaxis syndicated feed, custom widget, or your favorite custom stock ticker
Check out Trending Equities. Please also try Pattern Recognition module to use different pattern recognition models to time the market across multiple global exchanges.
Company logos by clearbit
Macroaxis is not a registered investment advisor or broker/dealer. All investments, including stocks, funds, ETFs, or cryptocurrencies, are speculative and involve substantial risk of loss. We encourage our investors to invest carefully. Much of our information is derived directly from data published by companies or submitted to governmental agencies which we believe are reliable, but are without our independent verification. Therefore, we cannot assure you that the information is accurate or complete. We do not in any way warrant or guarantee the success of any action you take in reliance on our statements or recommendations. Also, note that past performance is not necessarily indicative of future results. All investments carry risk, and all investment decisions of an individual remain the responsibility of that individual. There is no guarantee that systems, indicators, or signals will result in profits or that they will not result in losses. All investors are advised to fully understand all risks associated with any investing they choose to do. Hypothetical or simulated performance is not indicative of future results. We make no representations or warranties that any investor will, or is likely to, achieve profits similar to those shown because hypothetical or simulated performance is not necessarily indicative of future results. For more information please visit our terms and condition page